MedTrace Logo

A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine

NCT00013897 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2011-05-04

No results posted yet for this study

Summary

The purpose of this study is to compare the effectiveness of treatment with BMS-232632 to that of efavirenz (EFV) when both are used with zidovudine (ZDV) and lamivudine (3TC).

Conditions

  • HIV Infections

Interventions

DRUG

Atazanavir

DRUG

Lamivudine/Zidovudine

DRUG

Efavirenz

Sponsors & Collaborators

Study Design

Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-02-28
Primary Completion
2003-04-30
Completion
2003-04-30

Countries

  • United States
  • Austria
  • Belgium
  • Canada
  • Chile
  • Costa Rica
  • France
  • Germany
  • Guatemala
  • Hungary
  • Israel
  • Italy
  • Malaysia
  • Panama
  • Peru
  • Portugal
  • Puerto Rico
  • Russia
  • South Africa
  • Spain
  • Switzerland
  • Thailand
  • United Kingdom
  • Venezuela

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00013897 on ClinicalTrials.gov